RB
Rejuvenate Bio Inc
SEC filingBiotechnology · San Diego, CA
Amount raised$19.5Msold at filing
Total offering$27M$7.6M still open
Investors in the raise35count reported to the SEC
FiledJun 18, 2026first sale Jun 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Noah DavidsohnExecutive Officer, Director
David ZhuDirector
Daniel OliverExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.